Global Point of Care Testing Market

Point of Care Testing Comprehensive Study by Type (Glucose Monitoring, Cardiac Markers, Infectious Diseases Testing, Cholesterol Testing, Coagulation Monitoring, Pregnancy And Fertility Testing, Hematology Testing, Blood Gas Testing, Others), Application (Infectious Disease, Non-Infectious Disease), Prescription (Prescription-Based Testing, OTC Testing), End User (Clinics, Home, Laboratories, Assisted living healthcare facilities, Hospitals) Players and Region - Global Market Outlook to 2026

Point of Care Testing Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Point of Care Testing Market Scope
Point-of-care testing (POCT) is also known as medical testing, which is to be done near the site of patient care with the help of specially trained healthcare professionals. These tests can be performed at the bedside and they typically involve urine and blood urine testing. The goal of POCT is the collection of specimen and obtain the accurate results in extremely short period of time at or near to the location of the patient. POCT is many times accomplished through use of the transportable, portable, and handheld instruments, such as blood glucose meter, INR meter. Bench analysers are also been available for electrolyte, blood gas, pH, metabolite and haemoglobin measurement. Urinalysis analysers are also available for accurate and rapid urine testing

Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Point of Care Testing market throughout the predicted period.

Abbott (United States), Roche (Switzerland), Siemens (Germany), Danaher (United States), Becton, Dickinson, and Company (United States), Johnson & Johnson (United States), Instrumentation Laboratory (United States), PTS Diagnostics (United States), Quidel (United States) and Chembio (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Sekisui Diagnostics (United States), Nova (United States), EKF Diagnostics (United Kingdom), AccuBioTech (China) and Trinity Biotech (United States).

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.

Segmentation Overview
The study have segmented the market of Global Point of Care Testing market by Type (Glucose Monitoring, Cardiac Markers, Infectious Diseases Testing, Cholesterol Testing, Coagulation Monitoring, Pregnancy And Fertility Testing, Hematology Testing, Blood Gas Testing and Others), by Application (Infectious Disease and Non-Infectious Disease) and Region with country level break-up.

On the basis of geography, the market of Point of Care Testing has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2020.

Market Leaders and their expansionary development strategies

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced the safety and efficacy data from the LUTONIX® Drug-Coated Balloon (DCB) IDE, level 1 clinical trial for a below-the-knee (BTK) indication
The U.S. Food and Drug Administration (FDA) regulates medical devices to assure their safety and effectiveness and develops, and carries out a national program designed to control unnecessary exposures to, and assure safe and efficacious use of, ionizing and non-ionizing radiation-emitting electronic products. The Center for Devices and Radiological Health (CDRH) is the component within the FDA that is responsible for this program

Market Trend
  • Rising usage of home based POC devices
  • Rising in the number of approvals of novel immunoassay techniques

Market Drivers
  • Increasing infectious diseases in the developing countries
  • Technological advancement and launching of new products

Opportunities
  • POC tests with multiplexing capabilities
  • Converting lab test to POC test

Restraints
  • Pricing pressure concerning to the reimbursement cuts and budget constraints
  • Stringent and time consuming regulatory policies

Challenges
  • High cost associated with the devices
  • Inadequate knowledge of using the devices


Key Target Audience
Point-of-care diagnostics manufacturing companies, Point-of-care diagnostics distribution companies, Clinical laboratories, Hospitals, clinics, and special areas (such as sports and military), Research institutes and clinical research organizations (CROs) and Market research and consulting firms

Report Objectives / Segmentation Covered

By Type
  • Glucose Monitoring
  • Cardiac Markers
  • Infectious Diseases Testing
  • Cholesterol Testing
  • Coagulation Monitoring
  • Pregnancy And Fertility Testing
  • Hematology Testing
  • Blood Gas Testing
  • Others
By Application
  • Infectious Disease
  • Non-Infectious Disease
By Prescription
  • Prescription-Based Testing
  • OTC Testing

By End User
  • Clinics
  • Home
  • Laboratories
  • Assisted living healthcare facilities
  • Hospitals

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing infectious diseases in the developing countries
      • 3.2.2. Technological advancement and launching of new products
    • 3.3. Market Challenges
      • 3.3.1. High cost associated with the devices
      • 3.3.2. Inadequate knowledge of using the devices
    • 3.4. Market Trends
      • 3.4.1. Rising usage of home based POC devices
      • 3.4.2. Rising in the number of approvals of novel immunoassay techniques
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
  • 5. Global Point of Care Testing, by Type, Application, Prescription, End User and Region (value) (2015-2020)
    • 5.1. Introduction
  • 6. Point of Care Testing: Manufacturers/Players Analysis
    • 6.1. Company Profile
      • 6.1.1. Abbott (United States)
        • 6.1.1.1. Business Overview
        • 6.1.1.2. Products/Services Offerings
        • 6.1.1.3. Financial Analysis
        • 6.1.1.4. SWOT Analysis
      • 6.1.2. Roche (Switzerland)
        • 6.1.2.1. Business Overview
        • 6.1.2.2. Products/Services Offerings
        • 6.1.2.3. Financial Analysis
        • 6.1.2.4. SWOT Analysis
      • 6.1.3. Siemens (Germany)
        • 6.1.3.1. Business Overview
        • 6.1.3.2. Products/Services Offerings
        • 6.1.3.3. Financial Analysis
        • 6.1.3.4. SWOT Analysis
      • 6.1.4. Danaher (United States)
        • 6.1.4.1. Business Overview
        • 6.1.4.2. Products/Services Offerings
        • 6.1.4.3. Financial Analysis
        • 6.1.4.4. SWOT Analysis
      • 6.1.5. Becton, Dickinson, and Company (United States)
        • 6.1.5.1. Business Overview
        • 6.1.5.2. Products/Services Offerings
        • 6.1.5.3. Financial Analysis
        • 6.1.5.4. SWOT Analysis
      • 6.1.6. Johnson & Johnson (United States)
        • 6.1.6.1. Business Overview
        • 6.1.6.2. Products/Services Offerings
        • 6.1.6.3. Financial Analysis
        • 6.1.6.4. SWOT Analysis
      • 6.1.7. Instrumentation Laboratory (United States)
        • 6.1.7.1. Business Overview
        • 6.1.7.2. Products/Services Offerings
        • 6.1.7.3. Financial Analysis
        • 6.1.7.4. SWOT Analysis
      • 6.1.8. PTS Diagnostics (United States)
        • 6.1.8.1. Business Overview
        • 6.1.8.2. Products/Services Offerings
        • 6.1.8.3. Financial Analysis
        • 6.1.8.4. SWOT Analysis
      • 6.1.9. Quidel (United States)
        • 6.1.9.1. Business Overview
        • 6.1.9.2. Products/Services Offerings
        • 6.1.9.3. Financial Analysis
        • 6.1.9.4. SWOT Analysis
      • 6.1.10. Chembio (United States)
        • 6.1.10.1. Business Overview
        • 6.1.10.2. Products/Services Offerings
        • 6.1.10.3. Financial Analysis
        • 6.1.10.4. SWOT Analysis
  • 7. Global Point of Care Testing Sale, by Type, Application, Prescription, End User and Region (value) (2021-2026)
    • 7.1. Introduction
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Company Basic Information, Sales Area and Its Competitors
  • Table 2. Company Basic Information, Sales Area and Its Competitors
  • Table 3. Company Basic Information, Sales Area and Its Competitors
  • Table 4. Company Basic Information, Sales Area and Its Competitors
  • Table 5. Company Basic Information, Sales Area and Its Competitors
  • Table 6. Company Basic Information, Sales Area and Its Competitors
  • Table 7. Company Basic Information, Sales Area and Its Competitors
  • Table 8. Company Basic Information, Sales Area and Its Competitors
  • Table 9. Company Basic Information, Sales Area and Its Competitors
  • Table 10. Company Basic Information, Sales Area and Its Competitors
  • Table 11. Research Programs/Design for This Report
  • Table 12. Key Data Information from Secondary Sources
  • Table 13. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Abbott (United States) Revenue, Net Income and Gross profit
  • Figure 5. Abbott (United States) Revenue: by Geography 2020
  • Figure 6. Roche (Switzerland) Revenue, Net Income and Gross profit
  • Figure 7. Roche (Switzerland) Revenue: by Geography 2020
  • Figure 8. Siemens (Germany) Revenue, Net Income and Gross profit
  • Figure 9. Siemens (Germany) Revenue: by Geography 2020
  • Figure 10. Danaher (United States) Revenue, Net Income and Gross profit
  • Figure 11. Danaher (United States) Revenue: by Geography 2020
  • Figure 12. Becton, Dickinson, and Company (United States) Revenue, Net Income and Gross profit
  • Figure 13. Becton, Dickinson, and Company (United States) Revenue: by Geography 2020
  • Figure 14. Johnson & Johnson (United States) Revenue, Net Income and Gross profit
  • Figure 15. Johnson & Johnson (United States) Revenue: by Geography 2020
  • Figure 16. Instrumentation Laboratory (United States) Revenue, Net Income and Gross profit
  • Figure 17. Instrumentation Laboratory (United States) Revenue: by Geography 2020
  • Figure 18. PTS Diagnostics (United States) Revenue, Net Income and Gross profit
  • Figure 19. PTS Diagnostics (United States) Revenue: by Geography 2020
  • Figure 20. Quidel (United States) Revenue, Net Income and Gross profit
  • Figure 21. Quidel (United States) Revenue: by Geography 2020
  • Figure 22. Chembio (United States) Revenue, Net Income and Gross profit
  • Figure 23. Chembio (United States) Revenue: by Geography 2020
List of companies from research coverage that are profiled in the study
  • Abbott (United States)
  • Roche (Switzerland)
  • Siemens (Germany)
  • Danaher (United States)
  • Becton, Dickinson, and Company (United States)
  • Johnson & Johnson (United States)
  • Instrumentation Laboratory (United States)
  • PTS Diagnostics (United States)
  • Quidel (United States)
  • Chembio (United States)
Additional players considered in the study are as follows:
Sekisui Diagnostics (United States) , Nova (United States) , EKF Diagnostics (United Kingdom) , AccuBioTech (China) , Trinity Biotech (United States)
Select User Access Type

Key Highlights of Report


Jun 2021 250 Pages 84 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Point of Care Testing Market Quantitative research analysis
Global Point of Care Testing Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Point of Care Testing study can be customized to meet your requirements. The market size breakdown by type [Glucose Monitoring, Cardiac Markers, Infectious Diseases Testing, Cholesterol Testing, Coagulation Monitoring, Pregnancy And Fertility Testing, Hematology Testing, Blood Gas Testing and Others], by end use application [Infectious Disease and Non-Infectious Disease].
The Point of Care Testing Market is gaining popularity and expected to see strong valuation by 2026.
According to AMA, the Global Point of Care Testing market is expected to see growth rate of %.

Know More About Global Point of Care Testing Market Report?

Have a Query? Click Here

Other Related Reports

Cerebral Angiography Comprehensive Study by Type (Magnetic Resonance Angiography (MRA), Computed Tomography Angiography (CTA), Conventional Angiography, Digital Subtraction Angiography (DSA), Cathete...
$ 3650
Medical Nutrition Comprehensive Study by Type (Enteral Nutrition, Parenteral Nutrition), Application (Infant, The Aged, People with Malnutrition, Other) Players and Region - Global Market Outlook to ...
$ 3500
Animal Wound Care Comprehensive Study by Type (Surgical Wound Care Products (Suture, Sealant and Glue), Advanced Wound Care Products (Film, Foam, Hydrogel, Hydrocolloid Dressing), Traditional Wound C...
$ 3750
Renal Dialysis Comprehensive Study by Type (Hemodialysis, Peritoneal dialysis), Dialysis Products (Dialysis Machines, Dialyzers, Dialysis Catheters, Others), Dialysis (Primary Dialysis, Secondary Di...
$ 3800
Cancer Insurance Comprehensive Study by Type (Lung Cancer, Liver Cancer), Application (Children, Adult) Players and Region - Global Market Outlook to 2030
$ 3500
Skin Diagnosis System Comprehensive Study by Type (Analysis System, Skin Imaging, Skin Biopsy, Others), Application (Hospital, Beauty Salon, SPA, Dermatology Clinic, Research and Institute, Others), ...
$ 3800